InsiderClue
Insiders · Profile

Miller Joseph M

Chief Financial Officer at Aurinia Pharmaceuticals · Chief Financial Officer at Avalo Therapeutics. Filing since 10 Jun 2019. CIK 0001746372

AUPH Aurinia Pharmaceuticals Inc. Chief Financial Officer · 6 trades AVTX Avalo Therapeutics, Inc. Chief Financial Officer · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AUPH Aurinia Pharmaceuticals Inc.
4 Mar 2025
Chief Financial Officer
Sold at will
56,154
$444.74K
8.9%
AUPH Aurinia Pharmaceuticals Inc.
3 Mar 2025
Chief Financial Officer
Sold at will
61,859
$494.87K
8.9%
AUPH Aurinia Pharmaceuticals Inc.
6 Mar 2024
Chief Financial Officer
Sold at will
34,811
$194.94K
6.6%
AUPH Aurinia Pharmaceuticals Inc.
2 Mar 2023
Chief Financial Officer
Sold, plan not stated
11,296
$100.99K
3.3%
AUPH Aurinia Pharmaceuticals Inc.
2 Mar 2022
Chief Financial Officer
Sold, plan not stated
3,060
$36.75K
31.6%
AUPH Aurinia Pharmaceuticals Inc.
11 May 2021
Chief Financial Officer
Bought
1,000
$9.74K
opened
AVTX Avalo Therapeutics, Inc.
10 Dec 2019
Chief Financial Officer
Bought
2,598
$7.40K
5.6%
AVTX Avalo Therapeutics, Inc.
10 Jun 2019
Chief Financial Officer
Bought
1,179
$3.36K
2.6%
8 decisions on file.